Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation.
Saved in:
| Title: | Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation. |
|---|---|
| Authors: | Zhang C; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Liu J; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Gu T; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Meng X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Cai X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Zhang J; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Chen Y; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China., Zhang D; Department of Orthopaedic, The First Hospital of Jilin University, Changchun, China. zhangdg@jlu.edu.cn., Wu Y; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China. ygwu@jlu.edu.cn. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Jun; Vol. 211 (3), pp. 637-648. Date of Electronic Publication: 2025 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40050525 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Gu+T%22">Gu T</searchLink>; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Meng+X%22">Meng X</searchLink>; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Cai+X%22">Cai X</searchLink>; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Zhang+D%22">Zhang D</searchLink>; Department of Orthopaedic, The First Hospital of Jilin University, Changchun, China. zhangdg@jlu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Wu+Y%22">Wu Y</searchLink>; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China. ygwu@jlu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2025 Jun; Vol. 211 (3), pp. 637-648. <i>Date of Electronic Publication: </i>2025 Mar 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40050525 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10549-025-07676-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 637 Titles: – TitleFull: Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang C – PersonEntity: Name: NameFull: Liu J – PersonEntity: Name: NameFull: Gu T – PersonEntity: Name: NameFull: Meng X – PersonEntity: Name: NameFull: Cai X – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Zhang D – PersonEntity: Name: NameFull: Wu Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1573-7217 Numbering: – Type: volume Value: 211 – Type: issue Value: 3 Titles: – TitleFull: Breast cancer research and treatment Type: main |
| ResultId | 1 |